Control group (n = 28) | CVVH group (n = 29) | P value | |
---|---|---|---|
Age | 38 ± 18 | 27 ± 8 | 0.06 |
Percentage TBSA | 58 ± 18 | 64 ± 18 | 0.21 |
Percentage full thickness | 43 ± 27 | 49 ± 22 | 0.37 |
Inhalation injury | 61% | 41% | 0.14 |
ISS | 36 ± 14 | 35 ± 13 | 0.80 |
APACHE II# | 36 ± 8 | 35 ± 5 | 0.76 |
MODS# | 13 ± 4 | 12 ± 3 | 0.53 |
SOFA# | 13 ± 4 | 13 ± 3 | 0.87 |
AKIN stage 3 | 71% | 70% | 0.84 |
BUN (mg/dl)* | 58 ± 26 | 46 ± 24 | 0.07 |
Creatinine (mg/dl)* | 2.8 ± 1 | 2.9 ± 2 | 0.88 |
Hospital day of T0 | 23 ± 26 | 17 ± 24 | 0.21 |
Septic shock | 43% | 42% | 0.94 |
Shock (all cause) | 68% | 72% | 0.50 |
ALI/ARDS | 71% | 55% | 0.20 |